Nektar Therapeutics earnings per share and revenue

NKTR earnings per share for the last quarter are -0.18 USD whereas the estimation was -0.20 USD which accounts for 9.55% surprise. Company revenue for the same period amounts to 24.12 M USD despite the estimated figure of 19.18 M USD. Estimated earnings per share for the next quarter are -0.13 USD, and revenue is expected to reach 36.60 M USD. Also watch annual changes over time to get a bigger picture of NKTR earnings per share and revenue dynamics.